Peddapaka J, Nasreen A, Sanam T, Shaik M, Swain B, Sanwer S
Future Med Chem. 2025; 17(4):435-447.
PMID: 39949271
PMC: 11834530.
DOI: 10.1080/17568919.2025.2463876.
Maji A, Himaja A, Nikhitha S, Rana S, Paul A, Samanta A
RSC Med Chem. 2024; 15(9):3057-3069.
PMID: 39309361
PMC: 11411633.
DOI: 10.1039/d4md00279b.
Kosinska K, Skora B, Holota S, Shepeta Y, Tabecka-Lonczynska A, Lesyk R
Cells. 2024; 13(12.
PMID: 38920636
PMC: 11202306.
DOI: 10.3390/cells13121007.
Messore A, Malune P, Patacchini E, Madia V, Ialongo D, Arpacioglu M
Pharmaceuticals (Basel). 2024; 17(5).
PMID: 38794220
PMC: 11124136.
DOI: 10.3390/ph17050650.
Elgubbi A, El-Helw E, Y A Alzahrani A, Ramadan S
RSC Adv. 2024; 14(9):5926-5940.
PMID: 38362078
PMC: 10867554.
DOI: 10.1039/d3ra07048d.
Novel Thiazolidinedione and Rhodanine Derivatives Regulate Glucose Metabolism, Improve Insulin Sensitivity, and Activate the Peroxisome Proliferator-Activated γ Receptor.
Al Neyadi S, Adem A, Amir N, Ghattas M, Abdou I, Salem A
ACS Omega. 2024; 9(5):5463-5484.
PMID: 38343951
PMC: 10851269.
DOI: 10.1021/acsomega.3c07149.
Design, synthesis and mechanistic anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives.
Ramadan W, Saber-Ayad M, Saleh E, Abdu-Allah H, El-Shorbagi A, Menon V
iScience. 2024; 27(1):108659.
PMID: 38235331
PMC: 10792193.
DOI: 10.1016/j.isci.2023.108659.
Green Synthetic Approaches of 2-Hydrazonothiazol-4(5)-ones Using Sustainable Barium Oxide-Chitosan Nanocomposite Catalyst.
Khalil K, Riyadh S, Bashal A, Abolibda T, Gomha S
Polymers (Basel). 2023; 15(18).
PMID: 37765671
PMC: 10534876.
DOI: 10.3390/polym15183817.
Discovery of benzoxazole-thiazolidinone hybrids as promising antibacterial agents against and species.
Cheerala V, Akhir A, Saxena D, Maitra R, Chopra S, Neelakantan S
RSC Med Chem. 2023; 14(9):1712-1721.
PMID: 37731699
PMC: 10507814.
DOI: 10.1039/d3md00290j.
Thiadiazole and Thiazole Derivatives as Potential Antimicrobial Agents.
Khamitova A, Berillo D, Lozynskyi A, Konechnyi Y, Mural D, Georgiyants V
Mini Rev Med Chem. 2023; 24(5):531-545.
PMID: 37448365
DOI: 10.2174/1389557523666230713115947.
Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics.
Sharma A, Sharma D, Saini N, Sharma S, Thakur V, Goyal R
Cancer Metastasis Rev. 2023; 42(3):847-889.
PMID: 37204562
PMC: 10584807.
DOI: 10.1007/s10555-023-10106-1.
A Review of the Development of Multitarget Molecules against HIV-TB Coinfection Pathogens.
Leite D, de Castro Bazan Moura S, da Conceicao Avelino Dias M, Costa C, Machado G, Pimentel L
Molecules. 2023; 28(8).
PMID: 37110574
PMC: 10143421.
DOI: 10.3390/molecules28083342.
Structure-Activity Relationships Reveal Beneficial Selectivity Profiles of Inhibitors Targeting Acetylcholinesterase of Disease-Transmitting Mosquitoes.
Vidal-Albalat A, Kindahl T, Rajeshwari R, Lindgren C, Forsgren N, Kitur S
J Med Chem. 2023; 66(9):6333-6353.
PMID: 37094110
PMC: 10184127.
DOI: 10.1021/acs.jmedchem.3c00234.
Designing of thiazolidinones against chicken pox, monkey pox, and hepatitis viruses: A computational approach.
Raza M, Farwa U, Ishaque F, Al-Sehemi A
Comput Biol Chem. 2023; 103:107827.
PMID: 36805155
PMC: 9922439.
DOI: 10.1016/j.compbiolchem.2023.107827.
Synthesis and Antimicrobial Activity of New Heteroaryl(aryl) Thiazole Derivatives Molecular Docking Studies.
Kartsev V, Geronikaki A, Zubenko A, Petrou A, Ivanov M, Glamoclija J
Antibiotics (Basel). 2022; 11(10).
PMID: 36289995
PMC: 9658463.
DOI: 10.3390/antibiotics11101337.
Designing of Thiazolidinones for COVID-19 and its Allied Diseases: An Evaluation.
Raza M, Farwa U, Ain N, Ishaque F, Yaseen M, Naveed M
ChemistrySelect. 2022; 7(36):e202201793.
PMID: 36249082
PMC: 9538587.
DOI: 10.1002/slct.202201793.
Conformational Properties and Putative Bioactive Targets for Novel Thiosemicarbazone Derivatives.
Georgiou N, Cheilari A, Karta D, Chontzopoulou E, Plavec J, Tzeli D
Molecules. 2022; 27(14).
PMID: 35889421
PMC: 9324535.
DOI: 10.3390/molecules27144548.
Synthesis of new 2-(5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-ylimino)thiazolidin-4-one derivatives as anti-MRSA and anti-H. pylori agents.
Tabei A, Ejtemaei R, Mahboubi A, Saniee P, Foroumadi A, Dehdari A
BMC Chem. 2022; 16(1):38.
PMID: 35624517
PMC: 9145458.
DOI: 10.1186/s13065-022-00829-7.
2-{5-[(,2)-2-Chloro-3-(4-nitrophenyl)-2-propenylidene]-4-oxo-2-thioxothiazolidin-3-yl}-3-methylbutanoic Acid as a Potential Anti-Breast Cancer Molecule.
Buzun K, Gornowicz A, Lesyk R, Kryshchyshyn-Dylevych A, Gzella A, Czarnomysy R
Int J Mol Sci. 2022; 23(8).
PMID: 35456915
PMC: 9032233.
DOI: 10.3390/ijms23084091.
Iron-catalyzed intermolecular cross-dehydrogenative C(sp)-H/C(sp)-H coupling of pyrimidine bearing 4-thiazolidinones with terminal alkynes.
Morja M, Chikhalia K
Mol Divers. 2022; 26(6):3037-3045.
PMID: 35307757
DOI: 10.1007/s11030-021-10363-8.